Clinical and Molecular Hepatology

Scope & Guideline

Elevating understanding and treatment of liver conditions.

Introduction

Welcome to the Clinical and Molecular Hepatology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Clinical and Molecular Hepatology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2287-2728
PublisherKOREAN ASSOC STUDY LIVER
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 2012 to 2024
AbbreviationCLIN MOL HEPATOL / Clin. Mol. Hepatol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRM A1210, 53 MAPO-DAERO, MAPOTRAPALACE, DOWHA-DONG, MAPO-GU, SEOUL 04158, SOUTH KOREA

Aims and Scopes

The journal 'Clinical and Molecular Hepatology' focuses on advancing research and clinical practices related to liver diseases. It aims to disseminate significant findings that contribute to the understanding, diagnosis, treatment, and prevention of various hepatobiliary conditions.
  1. Hepatitis B and C Virus Research:
    A major focus on the molecular mechanisms, therapeutic strategies, and clinical outcomes related to hepatitis B and C infections, including studies on antiviral treatments, biomarkers, and patient management.
  2. Hepatocellular Carcinoma (HCC) Insights:
    Research dedicated to understanding the epidemiology, risk factors, prevention strategies, and treatment modalities for hepatocellular carcinoma, including surgical and non-surgical interventions.
  3. Metabolic Dysfunction-Associated Liver Diseases:
    Exploration of metabolic liver diseases, particularly the transition from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease (MASLD), and their clinical implications.
  4. Liver Transplantation and Regenerative Medicine:
    Studies focusing on advancement in liver transplantation techniques, donor-recipient matching, and the role of stem cells in liver regeneration and therapy.
  5. Clinical Guidelines and Real-World Practices:
    Dissemination of clinical practice guidelines and real-world evidence to improve management strategies and patient outcomes for liver diseases across diverse populations.
  6. Emerging Technologies in Hepatology:
    Incorporation of innovative methodologies such as machine learning and multi-omics approaches to enhance diagnostic accuracy and treatment efficacy in liver diseases.
The journal has identified several trending themes that are emerging as critical areas of interest in hepatology. These reflect the evolving landscape of liver disease research and clinical practice.
  1. Artificial Intelligence and Machine Learning Applications:
    The integration of AI and machine learning in predicting treatment outcomes and disease progression is on the rise, showcasing the potential for technology to enhance clinical decision-making.
  2. Multi-Omics Approaches:
    Research employing multi-omics profiling is gaining momentum, offering insights into the complex biological underpinnings of liver diseases and paving the way for personalized treatment strategies.
  3. Risk Stratification and Predictive Modeling:
    An increasing emphasis on developing risk scores and predictive models to identify high-risk patients for liver diseases, particularly in hepatocellular carcinoma and metabolic disorders.
  4. Patient-Centered Care in Liver Disease Management:
    A growing focus on patient-centered approaches that consider the individual needs and experiences of patients in the management of liver diseases, promoting better adherence and outcomes.
  5. Global Health Perspectives on Liver Diseases:
    Research that addresses the global burden of liver diseases, particularly in low- and middle-income countries, is gaining attention as the field recognizes the need for equitable healthcare access.

Declining or Waning

While the journal has seen significant growth in various research areas, certain scopes appear to be declining in prominence. This may reflect shifting priorities in the field or advancements in understanding that reduce the need for certain types of studies.
  1. Traditional Histological Techniques:
    There is a noticeable decrease in studies relying solely on traditional histological evaluations for liver diseases, as more non-invasive and advanced imaging techniques gain traction.
  2. Focus on Alcohol-Related Liver Disease:
    Research specifically targeting alcohol-related liver disease seems to be less frequent as the focus shifts towards metabolic and viral liver diseases, which are becoming more prevalent.
  3. Single-Agent Therapeutics:
    The exploration of single-agent therapies for liver diseases is waning in favor of combination therapies and personalized medicine approaches that consider patient-specific factors.
  4. Non-viral Hepatitis Research:
    Research on non-viral forms of hepatitis has seen a decline, likely overshadowed by the urgent need to address viral hepatitis and its associated complications.

Similar Journals

WORLD JOURNAL OF GASTROENTEROLOGY

Pioneering discoveries for better digestive health.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1007-9327Frequency: 48 issues/year

WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.

International Journal of Hepatology

Championing innovative discoveries in hepatology.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Translational Gastroenterology and Hepatology

Advancing Patient Outcomes through Translational Research.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Saudi Journal of Gastroenterology

Championing open access to vital gastroenterological findings.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.

Cellular and Molecular Gastroenterology and Hepatology

Exploring breakthroughs in cellular and molecular research.
Publisher: ELSEVIER INCISSN: 2352-345XFrequency: 12 issues/year

Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Innovative insights into digestive and liver health.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

DIGESTIVE AND LIVER DISEASE

Connecting professionals through groundbreaking studies.
Publisher: ELSEVIER SCIENCE INCISSN: 1590-8658Frequency: 12 issues/year

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

Liver Cancer

Empowering insights into liver neoplasms.
Publisher: KARGERISSN: 2235-1795Frequency: 6 issues/year

Liver Cancer is a premier, peer-reviewed journal dedicated to the comprehensive study and advancement of knowledge surrounding liver neoplasms. Published by KARGER and headquartered in Switzerland, this journal has been an open-access platform since 2012, providing researchers with invaluable insights into the rapidly evolving field of hepatology and oncology. With an impressive impact factor that places it in the Q1 category for both Hepatology and Oncology in 2023, Liver Cancer stands out as a high-impact conduit for groundbreaking research, ranking #19 out of 404 in Medicine _ Oncology and #6 out of 82 in Medicine _ Hepatology according to Scopus. Researchers, practitioners, and students are encouraged to engage with the journal's content, which encompasses clinical studies, basic research, and reviews that contribute significantly to understanding liver cancer dynamics, diagnosis, and treatment strategies. This journal not only facilitates the dissemination of knowledge but also fosters collaboration in a well-established and impactful global scientific community.

Korean Journal of Gastroenterology

Exploring Innovations in Gastroenterology
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Hepatology International

Innovating hepatology for a healthier tomorrow.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.